Repligen Historical Income Statement
| RGEN Stock | USD 151.94 2.78 1.80% |
Historical analysis of Repligen income statement accounts such as Other Operating Expenses of 967.5 M, Operating Income of 57.3 M, EBIT of 59 M or Ebitda of 130.5 M can show how well Repligen performed in making a profits. Evaluating Repligen income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Repligen's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Repligen latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Repligen is a good buy for the upcoming year.
Repligen |
About Repligen Income Statement Analysis
Repligen Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Repligen shareholders. The income statement also shows Repligen investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Repligen Income Statement Chart
Add Fundamental
Total Revenue
Total revenue comprises all receipts Repligen generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Repligen. It is also known as Repligen overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Most accounts from Repligen's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Repligen current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Repligen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. To learn how to invest in Repligen Stock, please use our How to Invest in Repligen guide.At this time, Repligen's EBITDA is very stable compared to the past year. As of the 11th of December 2024, Income Before Tax is likely to grow to about 67.3 M, while Depreciation And Amortization is likely to drop about 43.7 M.
| 2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 391.3M | 455.7M | 284.2M | 538.9M | Total Revenue | 670.5M | 801.5M | 638.8M | 768.0M |
Repligen income statement Correlations
Click cells to compare fundamentals
Repligen Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Repligen income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Depreciation And Amortization | 20.9M | 27.1M | 38.4M | 51.0M | 68.1M | 43.7M | |
| Interest Expense | 9.3M | 12.1M | 12.7M | 1.2M | 10.0M | 10.5M | |
| Total Revenue | 270.2M | 366.3M | 670.5M | 801.5M | 638.8M | 768.0M | |
| Gross Profit | 151.1M | 209.6M | 391.3M | 455.7M | 284.2M | 538.9M | |
| Other Operating Expenses | 234.2M | 296.4M | 497.4M | 605.6M | 584.2M | 967.5M | |
| Operating Income | 14.9M | 42.5M | 133.5M | 133.6M | 54.6M | 57.3M | |
| Ebit | 14.9M | 74.6M | 173.1M | 195.9M | 56.2M | 59.0M | |
| Ebitda | 35.8M | 101.6M | 211.6M | 246.9M | 124.3M | 130.5M | |
| Cost Of Revenue | 119.1M | 156.6M | 279.3M | 345.8M | 354.5M | 229.1M | |
| Total Operating Expenses | 115.1M | 139.8M | 218.1M | 259.8M | 230.3M | 218.8M | |
| Income Before Tax | 26.2M | 59.2M | 153.5M | 219.1M | 64.1M | 67.3M | |
| Total Other Income Expense Net | 11.3M | (10.6M) | (13.7M) | (5.5M) | 9.6M | 14.5M | |
| Net Income | 21.4M | 59.9M | 128.3M | 186.0M | 41.6M | 43.7M | |
| Income Tax Expense | 4.7M | (709K) | 25.3M | 33.2M | 22.6M | 23.7M | |
| Research Development | 19.5M | 20.2M | 34.3M | 43.9M | 42.7M | 40.6M | |
| Selling General Administrative | 95.6M | 119.6M | 183.9M | 215.8M | 213.8M | 353.8M | |
| Net Income Applicable To Common Shares | 21.4M | 59.9M | 128.3M | 186.0M | 213.9M | 224.5M | |
| Net Income From Continuing Ops | 21.4M | 59.9M | 128.3M | 186.0M | 115.8M | 121.6M | |
| Non Operating Income Net Other | (640K) | 1.5M | (992K) | (4.4M) | (3.9M) | (3.7M) | |
| Tax Provision | 4.7M | (709K) | 25.3M | 33.2M | 10.1M | 7.4M | |
| Net Interest Income | (9.3M) | (12.1M) | (12.7M) | (3.0M) | (2.9M) | (3.1M) | |
| Reconciled Depreciation | 20.9M | 27.1M | 38.4M | 51.0M | 65.3M | 36.0M |
Pair Trading with Repligen
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Repligen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Repligen will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Repligen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Repligen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Repligen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Repligen to buy it.
The correlation of Repligen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Repligen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Repligen moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Repligen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Repligen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. To learn how to invest in Repligen Stock, please use our How to Invest in Repligen guide.You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Repligen. If investors know Repligen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Repligen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.83) | Earnings Share (0.03) | Revenue Per Share 11.452 | Quarterly Revenue Growth 0.097 | Return On Assets 0.002 |
The market value of Repligen is measured differently than its book value, which is the value of Repligen that is recorded on the company's balance sheet. Investors also form their own opinion of Repligen's value that differs from its market value or its book value, called intrinsic value, which is Repligen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Repligen's market value can be influenced by many factors that don't directly affect Repligen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Repligen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Repligen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Repligen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.